Log in

Tekla Healthcare Investors Stock Price, News & Analysis (NYSE:HQH)

$18.49
-0.13 (-0.70 %)
(As of 10/21/2019 03:56 AM ET)
Today's Range
$18.42
Now: $18.49
$18.66
50-Day Range
$17.81
MA: $18.55
$19.10
52-Week Range
$16.50
Now: $18.49
$21.83
Volume136,913 shs
Average Volume173,778 shs
Market Capitalization$782.87 million
P/E RatioN/A
Dividend Yield9.77%
Beta1.49
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Industry, Sector and Symbol

Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone617-772-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$782.87 million
Next Earnings DateN/A
OptionableNot Optionable

Receive HQH News and Ratings via Email

Sign-up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.


Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions

What is Tekla Healthcare Investors' stock symbol?

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?

Tekla Healthcare Investors announced a quarterly dividend on Friday, August 16th. Investors of record on Wednesday, August 28th will be given a dividend of $0.45 per share on Monday, September 30th. This represents a $1.80 dividend on an annualized basis and a yield of 9.73%. The ex-dividend date of this dividend is Tuesday, August 27th. View Tekla Healthcare Investors' Dividend History.

Has Tekla Healthcare Investors been receiving favorable news coverage?

News coverage about HQH stock has trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tekla Healthcare Investors earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Tekla Healthcare Investors.

Who are some of Tekla Healthcare Investors' key competitors?

What other stocks do shareholders of Tekla Healthcare Investors own?

Who are Tekla Healthcare Investors' key executives?

Tekla Healthcare Investors' management team includes the folowing people:
  • Dr. Daniel R. Omstead M.S, Ph.D., CEO, Pres & Trustee (Age 66)
  • Ms. Kimberley L. Carroll, CFO, CFO - HQL Fund, VP & Treasurer of Hambrecht & Quist Capital Mgmt LLC (Age 63)
  • Ms. Laura F. Woodward, Chief Compliance Officer, Treasurer and Sec. (Age 51)
  • Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.
  • Mr. Christopher F. Brinzey, Sr. VP of Research and Portfolio Mang.

Who are Tekla Healthcare Investors' major shareholders?

Tekla Healthcare Investors' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Karpus Management Inc. (0.85%), Stephens Inc. AR (0.08%), Wedbush Securities Inc. (0.07%), North Star Investment Management Corp. (0.01%) and Optimum Investment Advisors (0.00%). Company insiders that own Tekla Healthcare Investors stock include Daniel R Omstead and Thomas M Kent. View Institutional Ownership Trends for Tekla Healthcare Investors.

Which institutional investors are selling Tekla Healthcare Investors stock?

HQH stock was sold by a variety of institutional investors in the last quarter, including Karpus Management Inc., Wedbush Securities Inc. and Optimum Investment Advisors. View Insider Buying and Selling for Tekla Healthcare Investors.

Which institutional investors are buying Tekla Healthcare Investors stock?

HQH stock was acquired by a variety of institutional investors in the last quarter, including Stephens Inc. AR and North Star Investment Management Corp.. Company insiders that have bought Tekla Healthcare Investors stock in the last two years include Daniel R Omstead and Thomas M Kent. View Insider Buying and Selling for Tekla Healthcare Investors.

How do I buy shares of Tekla Healthcare Investors?

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tekla Healthcare Investors' stock price today?

One share of HQH stock can currently be purchased for approximately $18.49.

How big of a company is Tekla Healthcare Investors?

Tekla Healthcare Investors has a market capitalization of $782.87 million. View Additional Information About Tekla Healthcare Investors.

What is Tekla Healthcare Investors' official website?

The official website for Tekla Healthcare Investors is http://www.teklacap.com/.

How can I contact Tekla Healthcare Investors?

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]


MarketBeat Community Rating for Tekla Healthcare Investors (NYSE HQH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  232
MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Investors and other stocks. Vote "Outperform" if you believe HQH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel